A Study Testing the Investigational Drug XmAb541 in people with Advanced Cancer

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-521981-90-00

Acronym

XmAb541-01

Enrollment

Registered

2025-10-27

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Solid Tumors

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, Denmark, France, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026